Invitrogen/Life Technologies (B) Harvard Case Solution & Analysis

Invitrogen/Life Technologies (B) Case Solution

On June 12, 2008, Invitrogen and Applied Biosystems revealed strategies to combine. The combined business was to become relabelled Life Technologies (NASDAQ: LIFE). Invitrogen used to obtain Employed Biosystems for $6.7 billion in money and stock. AB investors would get $38 per cooperate money and stock, speaking for a 17 percent premium over the share's closing cost on Wednesday, June 11, 2008.

This is just an excerpt. This case is about Business

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.